Quick Answer
Lipocine Inc. reported Shares Outstanding of 6.16 million shares for fiscal year 2025.
Lipocine Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 6.16M | +15.2% |
| 2024 | 5.35M | +0.6% |
| 2023 | 5.32M | +1.5% |
| 2022 | 5.23M | -94.1% |
| 2021 | 88.29M | +26.1% |
| 2020 | 70.04M | +86.0% |
| 2019 | 37.65M | +73.2% |
| 2018 | 21.73M | +2.2% |
| 2017 | 21.26M | +15.2% |
| 2016 | 18.46M | +1.2% |
| 2015 | 18.24M | +42.6% |
| 2014 | 12.79M | +1.0% |
| 2013 | 12.67M | +184.3% |
| 2012 | 4.46M | +48.5% |
| 2011 | 3.00M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 5.42M | +1.4% | +0.9% |
| June 30, 2025 | 5.37M | +0.5% | +0.4% |
| March 31, 2025 | 5.35M | +0.6% | +0.0% |
| December 31, 2024 | 5.35M | +0.6% | +0.0% |
| September 30, 2024 | 5.35M | +0.6% | +0.0% |
| June 30, 2024 | 5.35M | +2.2% | +0.6% |
| March 31, 2024 | 5.32M | -94.0% | +0.0% |
| December 31, 2023 | 5.32M | +1.5% | +0.0% |
- Lipocine Inc. showed an increase of +15.2% in Shares Outstanding compared to the prior fiscal year.
- Over the 2011–2025 period, Lipocine Inc.’s shares outstanding has grown by 105.3% (from 3.00 million shares to 6.16 million shares).
- The most recent figure is from Lipocine Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 10, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: